 |
 |

Cost-effectiveness of Total Knee Arthroplasty in the United States—Invited Commentary
Kevin Bozic, MD, MBA
Arch Intern Med. 2009;169(12):1121-1122.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Total knee arthroplasty (TKA) has proven to be a highly successful and reproducible intervention for patients with disabling arthritis of the knee that is refractory to nonoperative management.1-2 More than 500 000 TKA procedures are performed annually in the United States, and that number is expected to increase exponentially over the next 2 decades owing to an aging US population and an expansion of the indications for TKA to include younger, more active patients.3 Although the success of TKA has been well documented, concerns about increasing procedure volumes and rising costs per case, in part related to the use of newer, more expensive TKA implant technologies, have led to an increased interest in evaluating the cost-effectiveness of TKA.4
A growing body of literature has suggested that TKA outcomes are related to hospital and surgeon procedure volumes,5-6 with better patient outcomes and fewer complications reported among high-volume hospitals . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Cost-effectiveness of Total Knee Arthroplasty in the United States: Patient Risk and Hospital Volume
Elena Losina, Rochelle P. Walensky, Courtenay L. Kessler, Parastu S. Emrani, William M. Reichmann, Elizabeth A. Wright, Holly L. Holt, Daniel H. Solomon, Edward Yelin, A. David Paltiel, and Jeffrey N. Katz
Arch Intern Med. 2009;169(12):1113-1121.
ABSTRACT
| FULL TEXT
|